<DOC>
	<DOCNO>NCT01094847</DOCNO>
	<brief_summary>The purpose study compare explore bioavailability mosapride , main component DWJ1252 ( Test drug ) mosapride medicine ( Reference drug ) .</brief_summary>
	<brief_title>Clinical Trials Compare Mosapride Bioavailability Between DWJ1252 Mosapride Medicine</brief_title>
	<detailed_description />
	<mesh_term>Mosapride</mesh_term>
	<criteria>healthy adult male within range 20 50 year old time screen weight 55kg , range IBW 20 % : IBW ( kg ) = { height ( cm ) 100 } *0.9 understood completely study detailed explanation give , decide volunteer give write informed consent participate study compliance requirement entire protocol . one clinically significant disease liver , kidney , nerve system , respiratory system , endocrine system , blood , tumor , urinary system , cardiovascular system , mental disease medical history one gastrointestinal disease gastrointestinal surgical history affect absorption investigational drug . one genetic disease like galactose intolerance , Lapp lactase deficiency , glucosegalactose malabsorption one allergic clinically significant allergic history component investigational drug ( mosaprisde ) , component family , drug ( Aspirin , antibiotic , etc ) one show different rhythm sinus rhythm screening , like QTc &gt; 450ms electrocardiogram , PR interval &gt; 200msec QRS interval 120 &gt; msec one show follow result clinical laboratory test : AST , ALT &gt; 1.25 time upper limit normal range one show vital sign number systolic blood pressure 160 mmHg 100 mmHg , number diastolic blood pressure 95mmHg 60mmHg</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>